Tải xuống
Tóm tắt
Objectives: To investigate serum ferritin levels in patients with heart failure and to assess the correlation of ferritin, NT-proBNP levels with heart failure severity and between NT-proBNP and ferritin.
Methods: Cross - sectional description study on 101 patients diagnosed with heart failure and undergoing inpatient treatment at the Department of Internal Cardiology, Cardiovascular Center, Hue Central Hospital from 05/2022 to 08/2023.
Results: The average age of the study sample was 70.0 ± 16.4 years. Females constitute a higher proportion with a female/male ratio = 1.7. NYHA III heart failure accounted for the highest rate (47.5%). In terms of ejection fraction, EF ≥50% accounted for the highest rate of 54.5%. As many as 93 patients (92.1%) had anemia in the study. The incidence of ferritin reduction in the NYHA I/II heart failure group (57.4%) was higher than in NYHA III/IV (55.6%). Regarding ferritin and ejection fraction, ferritin decreased in the group with reduced EF at a rate of 56.1%, higher than in the group with non-reduced EF at a rate of 43.9%, however the difference was not statistically significant (p > 0.05). Anemia patients with reduced ferritin had significantly higher levels of NT-proBNP (14271.97 ± 12810.17 pg/ml) than the anemia group with normal ferritin (8255.60 ± 11121.41 pg/ml), p < 0.05. NT-proBNP has a moderate positive correlation with ferritin (r = 0.422; p < 0.05), a moderate negative correlation with RBC (r = -0.465; p < 0.05), Hb (r = -0.352; p < 0.05), HCT (r = -0.408; p < 0.05) in patients with heart failure according to NYHA III/IV.
Conclusions: Serum ferritin in patients with heart failure may be an indicator of iron deficiency. Our study shows that there is a positive correlation between NT-proBNP and ferritin in patients with severe heart failure.
Tài liệu tham khảo
Groenewegen A, Rutten FH, Mosterd A. Epidemiology of heart failure. European Journal of Heart Failure,. 2020;22(8):1342-1356.
Son DH, Hieu TB, Tuan PM, Huong NT. Serum iron deficiency in patients with chronic heart failure with reduced ejection fraction. Vietnam Journal of Cardiology. 2021;94 + 95:33-40.
Jelani QU, Katz SD. Treatment of anemia in heart failure: potential risks and benefits of intravenous iron therapy in cardiovascular disease. Cardiol Rev. 2010;18(5):240-50.
McDonagh TA, Metra M, Adamo M, Böhm M BH, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, . 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021;42(36):3599-3726.
Ebner N, von Haehling S. Why is Iron Deficiency Recognised as an Important Comorbidity in Heart Failure? Card Fail Rev. 2019;5(3):173-175.
Klip IT. Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J. 2013;165(4):575-582.
Tan KL, Ng SL, Chong SE, Isa W Y H W H, Tan J J, et al. (2020), “”, , pp. Iron Deficiency in Heart Failure Patients with Reduced Ejection Fraction and the Correlation with Left Ventricular Ejection Fraction. Malaysian Journal of Medicine and Health Sciences. 2020;16(1):126-130.
Anand IS, Gupta P. Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies. Circulation. 2018;138(1):80-98.
van der Wal HH, Grote BN, Dickstein K, Anker SD LC, Ng LL, van Veldhuisen DJ, Voors AA, van der Meer P,. Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet use. Eur Heart J. 2019;40(44):3616-3625.
Balkan C, Yakar TS, Basol G, Tuluce K, Ay Y. Relation between NT-ProBNP Levels, Iron Overload, and Early Stage of Myocardial Dysfunction in β-Thalassemia Major Patients. Echocardiography. 2011;29(3):318-325.
Anugrah D. Correlation between Ferritin Level and NTProBNP in Thalassemia Patient at M. Djamil Hospital Padang. International Journal of Research and Review. 2023;10(9):138-147.
Reina-Couto M, Pereira-Terra P, Quelhas-Santos J, Silva-Pereira C. Inflammation in Human Heart Failure: Major Mediators and Therapeutic Target. Front Physiol. 2021;12:746494.
Kell DB, Pretorius E. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Metallomics. 2014;6(4):748-73.
| Đã xuất bản | 28-12-2024 | |
| Toàn văn |
|
|
| Ngôn ngữ |
|
|
| Số tạp chí | Số 95 (2024) | |
| Phân mục | Nghiên cứu | |
| DOI | 10.38103/jcmhch.95.15 | |
| Từ khóa | Ferritin, NT-proBNP, heart failure Ferritin, NT-proBNP, heart failure |
công trình này được cấp phép theo Creative Commons Attribution-phi thương mại-NoDerivatives 4.0 License International .
Bản quyền (c) 2024 Tạp chí Y học lâm sàng Bệnh viện Trung Ương Huế